Incyte Corp
NASDAQ: INCY
$80.58
Closing Price on November 12, 2024
INCY Articles
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
Monday was a relatively positive day for the three major U.S. exchanges, but trading volumes were low as this is a truncated trading week. Crude oil was negative on the day. The S&P 500 sectors...
Published:
Last Updated:
The S&P 500 index closed up about 0.5% Wednesday on a day that saw all three major indexes finish on the up side.
Published:
Last Updated:
Overall Monday was a relatively flat day for the broad markets. Despite crude oil sliding lower on the day, Oil & Gas stocks were relatively mixed, with the likes of Exxon actually posting a...
Published:
Last Updated:
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.
Published:
Last Updated:
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
Published:
Last Updated:
Although Wednesday was the worst trading day that the markets have seen in 2016, Thursday the broad markets made a handy recovery. All of the sectors were positive in the index with only a few...
Published:
Last Updated:
Top Analyst Upgrades and Downgrades: Ambac, Bed Bath & Beyond, GE, Tiffany, Trade Desk and Many More
The top analyst upgrades, downgrades and other research calls on Friday include Ambac, Bed Bath & Beyond, General Electric, Tiffany and Trade Desk.
Published:
Last Updated:
When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and biotech companies can see harsh punishment.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and Snap.
Published:
Last Updated:
With earnings starting to really snowball next week, and a market that seems to be teetering somewhat due to high valuations and some messy geopolitical issues, it makes sense for investors to look...
Published:
Last Updated:
A massive new Jefferies research report reminds investors that as a rule the first quarter is traditionally slower for biotechnology stocks.
Published:
Last Updated:
The first quarter's top-performing stocks in the S&P 500 index included two pharmaceutical firms, an electricity generator, a video game maker and a media company.
Published:
Last Updated:
24/7 Wall St. tracked the best performing members of the S&P 500 Index on a year-to-date basis. It turns out that seven of the 500 stocks have gains of between 30% and 50%. That's no small...
Published:
Last Updated: